Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ARDT

Ardent Health (ARDT) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $11.30 +2.1% on the day -21.2% over 12 months 52-week range $7.83 – $15.21

Share price and insider trades

ARDT closeInsider buyInsider sale
810121518NovDecJan 2026FebMarAprMayJunJulAugSepOctEEarnings release filed 2025-11-12EEarnings release filed 2026-03-04EEarnings release filed 2026-05-05EEarnings release filed 2026-08-04Bought $186,400 on 2026-06-05 · Alfred Lumsdaine, Robert Demichiei
Bought, 12 months$186K
Sold, 12 months$0
Insiders buying2
Insiders selling0

Ardent Health insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $186K and 0 sold $0 of ARDT stock on the open market.

ARDT insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $186K bought (2 trades)$186KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$186K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.2×Last 5 sessions
Insiders' paper profit+$54KOn all tracked purchases +28.9%

Summary

Over the past 12 months, 2 Ardent Health, Inc. insiders reported open-market purchases totaling $186K, while 0 insiders reported sales totaling $0.

ARDT earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 4, 2026 +5.9% None +3.8%S&P +1.6% -2.2%
May 5, 2026 +0.7% None -6.1%S&P +2.2% -7.4%
Mar 4, 2026 -2.0% None +0.3%S&P +0.1% -8.3%
Nov 12, 2025 -7.2% None -33.8%S&P -1.6% -5.5%
Aug 5, 2025 -7.2% None +9.6%S&P +0.3% +16.5%
May 6, 2025 +5.3% None +7.9%S&P -0.4% +4.6%
Feb 26, 2025 -1.8% None +4.9%S&P -1.5% -12.9%
Jan 13, 2025 -5.3% None -11.1%S&P +0.3% +7.1%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jun 8SEC Robert DemichieiDirector Buy 11,26035,564 held (+46%) $8.73 $98K +29.4% —
Jun 8SEC Alfred LumsdaineCFO Buy 10,000329,183 held (+3%) $8.81 $88K +28.3% —

Insiders at Ardent Health, Inc.

InsiderBoughtSoldLast filingScore
Robert DemichieiDirector $98K — Jun 8, 2026 —
Alfred LumsdaineCFO $88K — Jun 8, 2026 —

ARDT stock: common questions

Are Ardent Health, Inc. insiders buying ARDT stock?

In the past 12 months, 2 insiders reported open-market purchases of ARDT worth $186K. The latest was Director Robert Demichiei bought $98K of ARDT at $8.73 — first open-market purchase in our records; raises the stake by 46%.

Are Ardent Health, Inc. insiders selling ARDT stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ARDT's 52-week range?

Over the past year ARDT has traded between $7.83 and $15.21. It last closed at $11.30 on Oct 9, 2026.